Changing spectrum of the diffuse infiltrative lymphocytosis syndrome

Arthritis Care and Research

Volumn 55, Issue 3, 2006, Pages 466-472

  Basu, Dhiman ^a   Williams, Francis M ^a   Ahn, Chul W ^a   Reveille, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

HAART; HIV infection; Parotid enlargement; Sj gren's syndrome

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; VIRUS ANTIGEN;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL FEATURE; DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTIC INTERSTITIAL PNEUMONIA; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MORTALITY; OPPORTUNISTIC INFECTION; PAROTID GLAND DISEASE; PAROTID GLAND SWELLING; PNEUMONIA; PREVALENCE; SJOEGREN SYNDROME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTOSIS; MIDDLE AGED; PAROTID DISEASES; PAROTID GLAND; RETROSPECTIVE STUDIES; SALIVARY GLANDS, MINOR; SURVIVAL RATE; TEXAS;

EID: 33745063671     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21980     Document Type: Article

References (22)

1. Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990;112:3-10.
2. Itescu S, Brancato LJ, Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989;26:466-8.
3. Williams FM, Cohen PR, Jumshyd J, Reveille JD. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 1998;41:863-8.
4. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as sicca syndrome. Rheum Dis Clin North Am 1992;18:683-97.
5. Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients. AIDS 1996;10:385-91.
6. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-13.
7. Olsen ML, Arnett FC, Reveille JD. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1993;36:94-104.
8. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-56.
9. Rosenberg ZS, Joffe SA, Itescu S. Spectrum of salivary gland disease in HIV-infected patients: characterization with Ga-67 citrate imaging. Radiology 1992;184:761-4.
10. Itescu S, Rose S, Dwyer E, Winchester R. Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci U S A 1994;91:11472-6.
11. Kordossis T, Paikos S, Aroni K, Kitsanta P, Dimitrakopoulos A, Kavouklis E, et al. Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998;37:691-5.
12. McArthur CP, Subtil-DeOliveira A, Palmer D, Fiorella RM, Gustafson S, Tira D, et al. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa. Arch Pathol Lab Med 2000;124:1773-9.
13. Panayiotakopoulos GD, Aroni K, Kyriaki D, Paikos S, Vouyioukas N, Vlachos A, et al. Paucity of Sjögren-like syndrome in a cohort of HIV-1-positive patients in the HAART era: part II. Rheumatology (Oxford) 2003;42:1164-7.
14. Talal N, Flescher E, Dang H. Evidence for possible retroviral involvement in autoimmune diseases. Ann Allergy 1992;69:221-4.
15. Shattles WG, Brookes SM, Venables PJ, Clark DA, Maini RN. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1992;89:46-51.
16. Willoughby CE, Baker K, Kaye SB, Carey P, O'Donnell N, Field A, et al. Epstein-Barr virus (types 1 and 2) in the tear film in Sjögren's syndrome and HIV infection. J Med Virol 2002;68:378-83.
17. Fox RI, Luppi M, Rang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Semin Immunopathol 1991;13:217-31.
18. Hansen A, Feist E, Hiepe F, Burmester GR, Scholze J. Diffuse inflltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1. Arthritis Rheum 1999;42:578-80.
19. Lee-Wing MW, Hodge WG, Diaz-Mitoma F. Investigating a viral etiology for keratoconjunctivitis sicca among patients who are positive for human immunodeficiency virus. Cornea 1999;18:671-4.
20. Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol 2004;15:503-7.
21. Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 2002;134:190-5.
22. Ramos-Casals M, Loustaud-Ratti V, de Vita S, Zeher M, Bosch JA, Toussirot E, et al, and the SS-HCV Study Group. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005;84:81-9.